Literature DB >> 24117134

Prevalence of intimate partner violence among women seeking termination of pregnancy compared to women seeking contraceptive counseling.

Mariella Öberg1, Kristina Stenson, Alkistis Skalkidou, Gun Heimer.   

Abstract

OBJECTIVE: To estimate the prevalence of intimate partner violence (IPV) among women seeking termination of pregnancy (TOP) in comparison to women seeking contraceptive counseling.
DESIGN: Case-control study.
SETTING: Family planning unit, Uppsala University Hospital. POPULATION: Women seeking TOP (n = 635) and women seeking contraceptive counseling (n = 591) answered a self-administered questionnaire regarding experience of IPV. In addition, the women were interviewed by specially trained staff.
METHOD: Comparisons were made between the two groups and between those who had previously undergone TOP and those who had never done so with experience of IPV as the main outcome measure. Multivariate logistic regression was used to adjust for age, education and occupation.
RESULTS: In total, 29% of women seeking TOP and 22% of women seeking contraceptive counseling reported experience of violence. Women seeking TOP were more likely to report physical violence [adjusted odds ratio (aOR) = 1.6, 95% confidence interval (CI) 1.2-2.1] and experience of violence during the past year (aOR = 2.3, 95% Cl 1.1-4.8). Women who had ever undergone TOP were also more likely to report IPV compared with women with no history of TOP (aOR = 1.7, 95% CI 1.3-2.3). Among women with repeated TOP, 51% reported experience of IPV.
CONCLUSION: Women seeking TOP reported to a greater extent experience of IPV. However, women seeking contraceptive counseling also had a high prevalence of violent experiences. These results stress the importance of caregivers approaching both groups of women with questions about IPV to identify exposed women and offer them help.
© 2013 Nordic Federation of Societies of Obstetrics and Gynecology.

Entities:  

Keywords:  Intimate partner violence; contraceptive counseling; family planning; interpersonal; repeated termination of pregnancy; termination of pregnancy; violence

Mesh:

Year:  2013        PMID: 24117134     DOI: 10.1111/aogs.12279

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  6 in total

1.  Intimate Partner Violence and Effectiveness Level of Contraceptive Selection Post-Abortion.

Authors:  Laura B Drew; Mona Mittal; Marie E Thoma; Cynthia C Harper; Julia R Steinberg
Journal:  J Womens Health (Larchmt)       Date:  2019-11-14       Impact factor: 2.681

2.  Midwives and women's perspectives on family planning in Jordan: human rights, gender equity, decision-making and power dynamics.

Authors:  Nihaya A Al-Sheyab; Mohannad Al Nsour; Yousef S Khader; Hind Yousif; Mohammad S Alyahya; Hana Taha; Marco Bardus; Malika Al Kattan; Mirwais Amiri
Journal:  Heliyon       Date:  2021-08-14

3.  Being a bridge: Swedish antenatal care midwives' encounters with Somali-born women and questions of violence; a qualitative study.

Authors:  Ulrika Byrskog; Pia Olsson; Birgitta Essén; Marie-Klingberg Allvin
Journal:  BMC Pregnancy Childbirth       Date:  2015-01-16       Impact factor: 3.007

4.  Preconception health and care (PHC)-a strategy for improved maternal and child health.

Authors:  Anna Berglund; Gunilla Lindmark
Journal:  Ups J Med Sci       Date:  2016-06-20       Impact factor: 2.384

5.  Neuroticism-related personality traits are associated with posttraumatic stress after abortion: findings from a Swedish multi-center cohort study.

Authors:  Inger Wallin Lundell; Inger Sundström Poromaa; Lisa Ekselius; Susanne Georgsson; Örjan Frans; Lotti Helström; Ulf Högberg; Agneta Skoog Svanberg
Journal:  BMC Womens Health       Date:  2017-10-02       Impact factor: 2.809

6.  Assessing for domestic violence in sexual health environments: a qualitative study.

Authors:  Jeremy Horwood; Andrew Morden; Jayne E Bailey; Neha Pathak; Gene Feder
Journal:  Sex Transm Infect       Date:  2017-08-04       Impact factor: 3.519

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.